Gene: IL17RE
Official Full Name: interleukin 17 receptor Eprovided by HGNC
Gene Summary: This gene encodes a transmembrane protein that functions as the receptor for interleukin-17C. The encoded protein signals to downstream components of the mitogen activated protein kinase (MAPK) pathway. Activity of this protein is important in the immune response to bacterial pathogens. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26544 | IL17RE Knockout cell line (HCT 116) | Human | IL17RE | 1:2~1:4 | Negative | Online Inquiry |
IL17RE Gene Knockout Cell Lines are specially engineered cell lines featuring a targeted deletion of the interleukin 17 receptor E (IL17RE) gene. This innovative product allows researchers to study the consequential effects of IL17RE signaling disruption in various biological contexts. By facilitating the elucidation of IL17 signaling pathways, these knockout cell lines serve as a valuable tool for probing the role of this receptor in inflammatory responses, immune regulation, and various disease processes.
The primary function of IL17RE is to act as a receptor for the IL-17 family of cytokines, which are key mediators in autoimmune conditions and chronic inflammation. By utilizing IL17RE Gene Knockout Cell Lines, researchers can effectively dissect the physiological roles of IL-17 signaling and its implications in health and disease. The precise mechanism of this product involves a CRISPR/Cas9-based gene editing approach, ensuring that the knockout is robust and can be reliably utilized across various experimental setups.
The scientific importance of these knockout cell lines cannot be overstated, particularly in research that seeks to unravel mechanisms underlying autoimmune diseases such as rheumatoid arthritis, psoriasis, and multiple sclerosis. Their application extends beyond basic research; these cell lines are instrumental in the development of targeted therapies and assessing the efficacy of novel therapeutic agents aimed at modulating the IL-17 pathway.
One of the key advantages of utilizing IL17RE Gene Knockout Cell Lines is their specificity, which allows for the isolation of variable responses in immunological studies. Unlike non-targeted approaches, these cells provide clear, interpretable data, reducing background noise, and enhancing signal clarity. Furthermore, with a background compatible with various in vitro assays, these cell lines simplify experimental workflows without compromising data quality.
For researchers and clinicians seeking to unlock the mysteries of IL-17 signaling, the value of IL17RE Gene Knockout Cell Lines is evident. They not only enhance the understanding of complex inflammatory processes but also pave the way for innovative therapeutic strategies. Backed by our company's commitment to advancing research through high-quality biological products, we provide researchers with reliable tools to drive their studies forward and make impactful discoveries in the field of immunology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.